Lezárult
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
NCT06000410· 3. fázis· Organogenesis· Forrás
Lezárult
A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure
NCT05952089· 1. fázis· Bristol-Myers Squibb· Forrás
Lezárult
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· 2. fázis· Shionogi· Forrás
Lezárult
Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain
NCT06703970· LifeBridge Health· Forrás
Lezárult
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
NCT04770337· Neuroelectrics Corporation· Forrás
Lezárult
Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
NCT04636229· 3. fázis· Organogenesis· Forrás
Leállították
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT04502316· CVRx, Inc.· Forrás
Lezárult
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
NCT03971474· 2. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT03845296· 2. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
NCT03526250· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
NCT03206450· Children's Oncology Group· Forrás
Lezárult
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
NCT03223753· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
NCT03213665· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
NCT03220035· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
NCT03213691· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
NCT03233204· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704· 4. fázis· Dartmouth-Hitchcock Medical Center· Forrás
Lezárult
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
NCT02723994· 2. fázis· Incyte Corporation· Forrás
Lezárult
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
NCT02717507· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
NCT02470091· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02498600· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
NCT01793233· Children's Oncology Group· Forrás
Lezárult
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
NCT01798004· 1. fázis· Children's Oncology Group· Forrás
Lezárult
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
NCT01668719· 1/2. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01371981· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
NCT01286272· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
NCT01231906· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT01167712· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
NCT00980954· 3. fázis· Radiation Therapy Oncology Group· Forrás
Lezárult
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
NCT00945009· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Lezárult
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
NCT00379340· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Collecting and Storing Tissue From Young Patients With Cancer
NCT00898755· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
NCT00352534· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
NCT00107198· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Forrás
Lezárult
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
NCT00217737· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
NCT00026312· 3. fázis· National Cancer Institute (NCI)· Forrás
Showing 50 of 51.